Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.

Detalhes bibliográficos
Autor(a) principal: Sterrantino, Carmel
Data de Publicação: 2016
Outros Autores: Duarte, Gonçalo, Costa, João, Vaz-Carneiro, António
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7526
Resumo: The common cold is an acute, self-limiting inflammation of the mucosa of the upper airways, which may involve one or all the sinuses, nasopharynx, oropharynx and larynx. It is common to have at least one episode per year. Common cold symptoms, which may include sore throat, sneezing, nasal congestion, runny nose, headache, malaise and mild fever usually disappear within a few days without treatment. The causative agent of most colds is rhinovirus. Although not associated with mortality, common cold is associated with significant morbidity. There is no vaccine or cure for common cold and, therefore, their treatment is centered on relieving the symptoms. This Cochrane review aimed to synthesize the existing evidence about the clinical benefit of antihistamines, used as monotherapy, compared with placebo or no treatment in children and adult patients with common cold. A total of 18 randomized clinical trials with 4342 participants were included. Main results were: 1) Antihistamines have a small (days one and two) beneficial effect in the short term on the severity of overall symptoms in adult patients, although this effect is not present in the medium to long term; 2) antihistamines were not associated with a clinically significant beneficial effect on the individual symptoms (nasal congestion, rhinorrhea, and sneezing); 3) Antihistamines are not associated with an increased risk of adverse effects; 4) No conclusion can be made about the effectiveness of antihistamines in pediatric populations. Our interpretation of the results is that the available evidence is insufficient to support the prescription or buying OTC antihistamines to relieve the symptoms of common cold without allergic component.
id RCAP_388908ffd41a4f0a1cc5b82f6e5c4fb8
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/7526
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.Análise da Revisão Cochrane: Antihistamínicos para a Constipação. Cochrane Database Syst Rev. 2015;11:CD009345.Common Cold/drug therapyHistamine H1 Antagonists/therapeutic useSystematic Review.Anti-Histamínicos/uso terapêuticoConstipação/tratamentoRevisão Sistemática.The common cold is an acute, self-limiting inflammation of the mucosa of the upper airways, which may involve one or all the sinuses, nasopharynx, oropharynx and larynx. It is common to have at least one episode per year. Common cold symptoms, which may include sore throat, sneezing, nasal congestion, runny nose, headache, malaise and mild fever usually disappear within a few days without treatment. The causative agent of most colds is rhinovirus. Although not associated with mortality, common cold is associated with significant morbidity. There is no vaccine or cure for common cold and, therefore, their treatment is centered on relieving the symptoms. This Cochrane review aimed to synthesize the existing evidence about the clinical benefit of antihistamines, used as monotherapy, compared with placebo or no treatment in children and adult patients with common cold. A total of 18 randomized clinical trials with 4342 participants were included. Main results were: 1) Antihistamines have a small (days one and two) beneficial effect in the short term on the severity of overall symptoms in adult patients, although this effect is not present in the medium to long term; 2) antihistamines were not associated with a clinically significant beneficial effect on the individual symptoms (nasal congestion, rhinorrhea, and sneezing); 3) Antihistamines are not associated with an increased risk of adverse effects; 4) No conclusion can be made about the effectiveness of antihistamines in pediatric populations. Our interpretation of the results is that the available evidence is insufficient to support the prescription or buying OTC antihistamines to relieve the symptoms of common cold without allergic component.A constipação representa uma inflamação aguda e autolimitada da mucosa das vias aéreas superiores, que pode envolver uma ou todas de entre os seios perinasais, rinofaringe, orofaringe e laringe. É comum ter-se pelo menos um episódio por ano. Os sintomas da constipação, que podem incluir dor de garganta, crises esternutatórias, congestão nasal, rinorreia, cefaleias, mal-estar e febre baixa geralmente desaparecem dentro de alguns dias sem tratamento. O agente etiológico da maioria das constipações é o rinovírus. Embora não esteja associado letalidade, a constipação é associada com morbidade significativa. Não existe vacina ou cura para a constipação e, portanto, o seu tratamento está centrado em aliviar os sintomas. Esta revisão Cochrane teve como objetivo sintetizar a evidência existente sobre o benefício clínico de anti-histamínicos, utilizados em monoterapia, em comparação com placebo ou nenhum tratamento, em crianças e em doentes adultos com constipação. Foram incluídos um total de 18 ensaios clínicos aleatorizados, com um total de 4 342 participantes. Os principais resultados foram: 1) Anti-histamínicos têm um pequeno (dias um e dois de tratamento) efeito benéfico a curto-prazo sobre a gravidade dos sintomas globais em doentes adultos, embora este efeito não esteja presente no médio a longo prazo; 2) Os anti-histamínicos foram associados com um efeito benéfico não clinicamente relevante sobre os sintomas individuais (congestão nasal, rinorreia e esternutos); 3) Os anti-histamínicos não estão associados com um risco aumentado de efeitos adversos; 4) Nenhuma conclusão pode ser feita sobre a eficácia dos anti-histamínicos em populações pediátricas. A nossa interpretação dos resultados é que a evidência disponível é insuficiente para apoiar a prescrição ou a compra de anti-histamínicos de venda-livre para aliviar os sintomas da constipação sem componente alérgico.Ordem dos Médicos2016-03-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7526oai:ojs.www.actamedicaportuguesa.com:article/7526Acta Médica Portuguesa; Vol. 29 No. 3 (2016): March; 164-167Acta Médica Portuguesa; Vol. 29 N.º 3 (2016): Março; 164-1671646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7526https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7526/4614Direitos de Autor (c) 2016 Copyright © Ordem dos Médicosinfo:eu-repo/semantics/openAccessSterrantino, CarmelDuarte, GonçaloCosta, JoãoVaz-Carneiro, António2022-12-20T11:05:15Zoai:ojs.www.actamedicaportuguesa.com:article/7526Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:28.246188Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.
Análise da Revisão Cochrane: Antihistamínicos para a Constipação. Cochrane Database Syst Rev. 2015;11:CD009345.
title Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.
spellingShingle Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.
Sterrantino, Carmel
Common Cold/drug therapy
Histamine H1 Antagonists/therapeutic use
Systematic Review.
Anti-Histamínicos/uso terapêutico
Constipação/tratamento
Revisão Sistemática.
title_short Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.
title_full Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.
title_fullStr Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.
title_full_unstemmed Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.
title_sort Analysis of the Cochrane Review: Antihistamines for the Common Cold. Cochrane Database Syst Rev. 2015;11:CD009345.
author Sterrantino, Carmel
author_facet Sterrantino, Carmel
Duarte, Gonçalo
Costa, João
Vaz-Carneiro, António
author_role author
author2 Duarte, Gonçalo
Costa, João
Vaz-Carneiro, António
author2_role author
author
author
dc.contributor.author.fl_str_mv Sterrantino, Carmel
Duarte, Gonçalo
Costa, João
Vaz-Carneiro, António
dc.subject.por.fl_str_mv Common Cold/drug therapy
Histamine H1 Antagonists/therapeutic use
Systematic Review.
Anti-Histamínicos/uso terapêutico
Constipação/tratamento
Revisão Sistemática.
topic Common Cold/drug therapy
Histamine H1 Antagonists/therapeutic use
Systematic Review.
Anti-Histamínicos/uso terapêutico
Constipação/tratamento
Revisão Sistemática.
description The common cold is an acute, self-limiting inflammation of the mucosa of the upper airways, which may involve one or all the sinuses, nasopharynx, oropharynx and larynx. It is common to have at least one episode per year. Common cold symptoms, which may include sore throat, sneezing, nasal congestion, runny nose, headache, malaise and mild fever usually disappear within a few days without treatment. The causative agent of most colds is rhinovirus. Although not associated with mortality, common cold is associated with significant morbidity. There is no vaccine or cure for common cold and, therefore, their treatment is centered on relieving the symptoms. This Cochrane review aimed to synthesize the existing evidence about the clinical benefit of antihistamines, used as monotherapy, compared with placebo or no treatment in children and adult patients with common cold. A total of 18 randomized clinical trials with 4342 participants were included. Main results were: 1) Antihistamines have a small (days one and two) beneficial effect in the short term on the severity of overall symptoms in adult patients, although this effect is not present in the medium to long term; 2) antihistamines were not associated with a clinically significant beneficial effect on the individual symptoms (nasal congestion, rhinorrhea, and sneezing); 3) Antihistamines are not associated with an increased risk of adverse effects; 4) No conclusion can be made about the effectiveness of antihistamines in pediatric populations. Our interpretation of the results is that the available evidence is insufficient to support the prescription or buying OTC antihistamines to relieve the symptoms of common cold without allergic component.
publishDate 2016
dc.date.none.fl_str_mv 2016-03-31
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7526
oai:ojs.www.actamedicaportuguesa.com:article/7526
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7526
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/7526
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7526
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/7526/4614
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2016 Copyright © Ordem dos Médicos
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2016 Copyright © Ordem dos Médicos
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 29 No. 3 (2016): March; 164-167
Acta Médica Portuguesa; Vol. 29 N.º 3 (2016): Março; 164-167
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130645734096896